See more : 3i Infotech Limited (3IINFOLTD.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Adams Diversified Equity Fund, Inc. (ADX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adams Diversified Equity Fund, Inc., a leading company in the Asset Management industry within the Financial Services sector.
You may be interested
- Repay Holdings Corporation (RPAY) Income Statement Analysis – Financial Results
- Weconnect Tech International, Inc. (WECT) Income Statement Analysis – Financial Results
- Allena Pharmaceuticals, Inc. (ALNA) Income Statement Analysis – Financial Results
- Knowledge Net Company (9561.SR) Income Statement Analysis – Financial Results
- Epigral Limited (EPIGRAL.NS) Income Statement Analysis – Financial Results
Adams Diversified Equity Fund, Inc. (ADX)
Industry: Asset Management
Sector: Financial Services
Website: https://www.adamsfunds.com/funds/diversified-equity
About Adams Diversified Equity Fund, Inc.
Adams Diversified Equity Fund, Inc. is a publicly owned investment manager. The firm provides its services to investment companies. The firm invests in the public equity markets of the United States. It invests in stocks of large-cap companies across diversified sectors to make its investments. The firm employs a fundamental, technical and quantitative analysis with a bottom-up stock picking approach, while focusing on earnings growth prospects, financial strength, cash flow generation, macro-economics, capital allocation, market competition, profitability. It obtains external research to complement its in-house research to make its investments. The firm benchmarks the performance of its portfolios against the S&P 500 Index. It was formerly known as The Adams Express Company. Adams Diversified Equity Fund, Inc. was founded in 1840 and is based in Baltimore, Maryland.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 173.82M | -458.78M | 638.99M | 361.70M | 490.69M | -51.61M | 382.90M | 106.20M | 101.43M | 27.71M | 27.53M | 24.94M | 19.94M | 19.41M | 19.61M | 26.66M | 32.12M | 26.23M | 23.97M | 24.34M | 20.69M | 20.80M | 24.16M | 26.17M | 24.82M | 25.95M | 25.79M | 27.79M |
| Cost of Revenue | 1.52M | 1.53M | 1.51M | 1.36M | 1.25M | 1.16M | 1.09M | 1.07M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 172.30M | -460.32M | 637.48M | 360.34M | 489.44M | -52.77M | 381.81M | 105.13M | 98.03M | 27.71M | 27.53M | 24.94M | 19.94M | 19.41M | 19.61M | 26.66M | 32.12M | 26.23M | 23.97M | 24.34M | 20.69M | 20.80M | 24.16M | 26.17M | 24.82M | 25.95M | 25.79M | 27.79M |
| Gross Profit Ratio | 99.12% | 100.33% | 99.76% | 99.62% | 99.74% | 102.25% | 99.72% | 98.99% | 96.65% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -3.40 | 1.83 | 2.81 | 3.00 | -0.29 | 2.58 | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.43M | 4.63M | 5.64M | 4.88M | 4.40M | 4.52M | 4.14M | 8.48M | 8.64M | 8.24M | 8.61M | 7.13M | 5.89M | 5.86M | 7.85M | 5.40M | 5.97M | 6.32M | 5.50M | 5.11M | 4.90M | 3.86M | 2.79M | 4.99M | 5.43M | 2.66M | 4.26M | 2.72M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -8.48M | 1.25M | 348.40K | 262.58K | 263.51K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 5.43M | 4.63M | 5.64M | 4.88M | 4.40M | 4.52M | 4.14M | 1.11 | 9.88M | 8.59M | 8.87M | 7.39M | 5.89M | 5.86M | 7.85M | 5.40M | 5.97M | 6.32M | 5.50M | 5.11M | 4.90M | 3.86M | 2.79M | 4.99M | 5.43M | 2.66M | 4.26M | 2.72M |
| Other Expenses | 0.00 | 7.71M | 8.26M | 6.87M | 7.53M | 5.54M | 5.23M | 99.44M | -81.72M | 77.33K | 30.00K | 340.00K | 790.00K | 10.00K | -3.67M | 4.23M | 430.00K | 220.00K | 180.00K | 230.00K | 180.00K | 200.00K | 280.00K | 240.00K | 250.00K | 710.00K | 740.00K | 830.00K |
| Operating Expenses | 517.78M | 12.34M | 13.90M | 11.75M | 11.94M | 10.06M | 9.37M | 89.33M | 81.72M | 160.84M | 299.28M | 121.16M | 6.68M | 5.87M | 4.18M | 9.63M | 6.40M | 6.54M | 5.68M | 5.34M | 5.08M | 4.06M | 3.07M | 5.23M | 5.68M | 3.37M | 5.00M | 3.55M |
| Cost & Expenses | -379.10M | 12.34M | 13.90M | 11.75M | 11.94M | 10.06M | 9.37M | 105.13M | 85.12M | 160.84M | 299.28M | 121.16M | 6.68M | 5.87M | 4.18M | 9.63M | 6.40M | 6.54M | 5.68M | 5.34M | 5.08M | 4.06M | 3.07M | 5.23M | 5.68M | 3.37M | 5.00M | 3.55M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 413.75K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 97.10M | 168.44M | 308.15M | 128.55M | 0.00 | 95.40M | 225.70M | 0.00 | 52.13M | 158.83M | 26.63M | 116.27M | 236.65M | -285.88M | -508.79M | -123.10M | 526.34M | 296.90M | 314.43M | 171.21M | |
| Depreciation & Amortization | -21.02M | -22.54M | -19.06M | -21.78M | -21.60M | -20.64M | -21.74M | -18.91M | -16.79M | -19.12M | -18.66M | -17.55M | -101.43M | 190.80M | 451.40M | -978.94M | 104.25M | 317.66M | 53.26M | 232.54M | 473.30M | -571.76M | -1.02B | -246.20M | 1.05B | 593.80M | 628.85M | 342.42M |
| EBITDA | 531.91M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | -11.40M | -5.20M | 169.43M | 308.15M | 128.55M | -88.17M | 204.34M | 466.83M | -961.91M | 129.98M | 337.35M | 71.55M | 251.55M | 488.91M | -555.02M | -996.49M | -225.26M | 1.07B | 616.38M | 649.64M | 366.66M |
| EBITDA Ratio | 306.00% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | -10.74% | 16.09% | 611.40% | 1,119.34% | 515.44% | -442.18% | 1,052.76% | 2,380.57% | -3,608.06% | 404.67% | 1,286.12% | 298.50% | 1,033.48% | 2,363.03% | -2,668.37% | -4,124.54% | -860.76% | 4,318.41% | 2,375.26% | 2,518.96% | 1,319.40% |
| Operating Income | 552.92M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | 18.91M | 16.32M | 19.12M | 18.66M | 17.55M | 13.26M | 13.54M | 15.43M | 17.03M | 25.73M | 19.69M | 18.29M | 19.01M | 15.61M | 16.74M | 21.09M | 20.94M | 19.14M | 22.58M | 20.79M | 24.24M |
| Operating Income Ratio | 318.09% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | 17.80% | 16.09% | 69.00% | 67.77% | 70.36% | 66.50% | 69.76% | 78.68% | 63.88% | 80.11% | 75.07% | 76.30% | 78.10% | 75.45% | 80.48% | 87.29% | 80.02% | 77.12% | 87.01% | 80.61% | 87.23% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.69M | -4.72M | 0.00 | 0.00 | 0.00 | -50.72M | 95.40M | 225.70M | -489.47M | 52.12M | 158.83M | 26.63M | 116.27M | 236.65M | -285.88M | -508.79M | -123.10M | 526.35M | 296.90M | 314.42M | 171.21M |
| Income Before Tax | 552.92M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | 117.60M | 11.59M | 188.55M | 326.81M | 146.10M | -37.46M | 108.94M | 241.13M | -472.44M | 77.85M | 178.52M | 44.92M | 135.28M | 252.26M | -269.14M | -487.70M | -102.16M | 545.49M | 319.48M | 335.21M | 195.45M |
| Income Before Tax Ratio | 318.09% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | 110.74% | 11.43% | 680.40% | 1,187.11% | 585.80% | -187.86% | 561.26% | 1,229.63% | -1,772.09% | 242.37% | 680.59% | 187.40% | 555.79% | 1,219.24% | -1,293.94% | -2,018.63% | -390.37% | 2,197.78% | 1,231.14% | 1,299.77% | 703.31% |
| Income Tax Expense | 0.00 | 22.54M | 19.06M | 21.78M | 478.76M | -161.14K | 373.53M | 117.60M | 16.79M | 169.43M | 308.15M | 128.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 552.92M | -471.12M | 625.09M | 349.95M | 478.76M | -61.67M | 373.53M | 117.60M | 11.59M | 188.55M | 326.81M | 146.10M | -37.46M | 108.94M | 241.13M | -472.44M | 77.85M | 178.52M | 44.92M | 135.28M | 252.26M | -269.14M | -487.70M | -102.16M | 545.49M | 319.48M | 335.21M | 195.45M |
| Net Income Ratio | 318.09% | 102.69% | 97.82% | 96.75% | 97.57% | 119.50% | 97.55% | 110.74% | 11.43% | 680.40% | 1,187.11% | 585.80% | -187.86% | 561.26% | 1,229.63% | -1,772.09% | 242.37% | 680.59% | 187.40% | 555.79% | 1,219.24% | -1,293.94% | -2,018.63% | -390.37% | 2,197.78% | 1,231.14% | 1,299.77% | 703.31% |
| EPS | 4.46 | -3.99 | 5.59 | 3.21 | 4.40 | -0.67 | 3.77 | 1.00 | 0.12 | 1.96 | 3.47 | 1.57 | -0.41 | 1.23 | 2.76 | -5.40 | 0.89 | 2.06 | 0.52 | 1.57 | 2.97 | -3.18 | -5.72 | -1.24 | 6.75 | 4.24 | 4.73 | 2.80 |
| EPS Diluted | 4.46 | -3.99 | 5.59 | 3.21 | 4.40 | -0.67 | 3.77 | 99.44M | 0.12 | 1.96 | 3.47 | 1.57 | -0.41 | 1.23 | 2.76 | -5.40 | 0.89 | 2.06 | 0.52 | 1.57 | 2.97 | -3.18 | -5.72 | -1.24 | 6.75 | 4.24 | 4.73 | 2.80 |
| Weighted Avg Shares Out | 124.05M | 118.08M | 111.82M | 109.02M | 108.87M | 92.04M | 99.08M | 117.60M | 97.91M | 96.29M | 94.22M | 93.03M | 91.07M | 88.89M | 87.42M | 87.41M | 87.67M | 86.84M | 86.10M | 86.14M | 84.89M | 84.54M | 85.23M | 82.29M | 80.84M | 75.27M | 70.86M | 69.91M |
| Weighted Avg Shares Out (Dil) | 124.05M | 118.08M | 111.82M | 109.02M | 108.87M | 92.04M | 99.08M | 1.18 | 97.91M | 96.29M | 94.22M | 93.03M | 91.07M | 88.89M | 87.42M | 87.41M | 87.67M | 86.84M | 86.10M | 86.14M | 84.89M | 84.54M | 85.23M | 82.29M | 80.84M | 75.27M | 70.86M | 69.91M |
5 Best CEFs This Month For 8.5% Yield (November 2024)
For income investors, closed-end funds remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. Closed-end funds, or CEFs, are generally characterized by higher volatility and deeper drawdowns than the broader market....
Potential $5,000 Monthly Income: 10 Investments To Buy And Hold For Next 10 Years
We present a highly diversified yet simple portfolio of 10 positions, with 9 funds and one individual MLP stock. The portfolio has been designed for retirees and investors planning for retirement, with a 6% current income yield and potentially 6%...
Adams Diversified Equity Fund Declares Year-End Distribution
BALTIMORE, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Adams Diversified Equity Fund, Inc. (NYSE: ADX) declared today a year-end distribution of $1.96 per share. The total distributions by the Fund for 2024 will be $2.50 per share, including the distributions totaling...
This 8% Dividend Is The Perfect Buy As Markets Turn Choppy
I get it if you're a bit wary of this latest market rally: We've got a volatile (to say the least!) election now days away.
High Yield Or Growth? Capture Both With These 2 Quality Picks
Usually, investors can access high yields with limited growth prospects, or relatively low yields with stronger and close to or even above double-digit income growth potential. However, in some instances, by being very selective and thoroughly assessing the fundamentals, it...
5 Best CEFs This Month For 9.5% Yield (October 2024)
For income investors, closed-end funds, or CEFs, remain an attractive investment class that covers various asset classes and promises high distributions and reasonable total returns. CEFs are generally characterized by higher volatility and deeper draw-downs than the broader market. For...
ADX: 8% Distribution Rate Policy And Discount Widening Back Out
The Adams Diversified Equity Fund provides an investor with a pretty plain S&P 500 Index-like exposure in a CEF wrapper. The fund completed a tender offer earlier this year that we were able to take advantage of; they further announced...
Adams Diversified Equity Fund Reports Nine Month Results
BALTIMORE, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Adams Diversified Equity Fund, Inc. (NYSE: ADX) today announced the Fund's results for the nine months ended September 30th. The total return on Adams Diversified Equity's net asset value, with dividends and capital...
Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024
-- Poster presentation to highlight data from completed first-in-human, Phase 1 ascending dose clinical trial of ADX-097 in healthy volunteers; results support Phase 2 dose selection and continued clinical advancement of ADX-097 -- WALTHAM, Mass. , Oct. 14, 2024 /PRNewswire/...
2 Picks For High-Yield Investors Who Seek Growth-Like Exposure
Income investors often favor value investments like midstream infrastructure, equity REITs, and blue-chip cash cows for yields between 5% to 8%. Long-term alpha-like returns are unlikely with these assets, but they offer stable income streams that are suitable for defensive...
Source: https://incomestatements.info
Category: Stock Reports